Navigation Links
NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance
Date:12/15/2010

SALT LAKE CITY, Dec. 15, 2010 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that NASDAQ has given the company until June 13, 2011, to comply with its $1 per share minimum bid rule.

"Given the challenges of the general economy, we welcome the grant by NASDAQ of an additional six months to cure the $1 minimum bid deficiency," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "These difficult economic times have made it challenging for small public companies to maintain strength in their stock prices.  This extra time will provide an opportunity for the market to better understand the potential of some important new developments that we expect to announce over the coming weeks and months."

"Dynatronics' newly introduced e-commerce website is positively impacting sales and helping the company operate more efficiently.  In addition, we are working to capitalize on preferred vendor contracts signed over the past year as well as identify and introduce new products to the market," Cullimore added.

"Our preferred vendor contracts give us access to over 2,500 clinics that we are working to convert to our brand of products. This promises to be a source of increased revenue over the coming year as more clinics choose to purchase our devices and supplies," Cullimore continued. "We believe all of these improvements, together with the new initiatives being undertaken that we expect to disclose in the coming weeks and months, should continue to strengthen our business and build investor confidence in owning our stock."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future announcements, increased revenue from preferred vendor contracts and continued strengthening in our business. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2010.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration
4. EntreMed Receives Notice of NASDAQ Compliance
5. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
6. ThermoGenesis Regains Compliance With NASDAQ Listing Rules
7. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8. ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010
9. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
10. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
11. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today that Rhino ... its network of more than 650 U.S.-based dealers. Rhino, a member of the Alamo ... flail mowers and cutters, rear blades, post hole diggers, pasture renovators, tillers, disc mowers ...
(Date:3/29/2017)... ... ... pollen is the main cause of hay fever in the United States, with an estimated ... from May to July each year; with the worst time for sufferers being June and ... ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear announced ... retails normally at $29.97; for the remaining days of March, the price will be ... to a special price of just $10 (regular retail price $19.97). , The special ...
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... ... March 29, 2017 , ... How big ... outpatient facilities, and who are the most active developers? , In the ... Healthcare Real Estate Insights (HREI) found that outpatient medical real estate development projects ...
Breaking Medicine News(10 mins):